Corcept Therapeutics (CORT) Change in Cash (2010 - 2026)

Corcept Therapeutics (CORT) has 17 years of Change in Cash data on file, last reported at -$11.8 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Cash rose 68.93% year-over-year to -$11.8 million; the trailing twelve-month figure through Mar 2026 stood at $18.9 million (up 131.57% YoY), and the FY2025 full-year result was -$7.2 million, up 9.08% from the prior year.
• Change in Cash retreated to -$11.8 million in Q1 2026, from -$4.6 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $233.6 million in Q1 2023 to a low of -$127.6 million in Q2 2023.
• A 5-year average of $1.8 million and a median of -$4.6 million in 2025 frame the typical range for Change in Cash.
• Across the five-year window, Change in Cash jumped 2107.68% in 2022 and tumbled 506.64% in 2023, its largest moves.
• Tracing CORT's Change in Cash over 5 years: stood at $16.1 million in 2022, then surged by 47.65% to $23.8 million in 2023, then plunged by 140.52% to -$9.6 million in 2024, then surged by 51.76% to -$4.6 million in 2025, then sank by 153.22% to -$11.8 million in 2026.
• Business Quant data shows CORT's Change in Cash at -$11.8 million in Q1 2026, -$4.6 million in Q4 2025, and $22.4 million in Q3 2025.